Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Effects of human impacts on habitat use, activity patterns and ecological relationships among medium and small felids of the Atlantic Forest.

Cruz P, Iezzi ME, De Angelo C, Varela D, Di Bitetti MS, Paviolo A.

PLoS One. 2018 Aug 1;13(8):e0200806. doi: 10.1371/journal.pone.0200806. eCollection 2018.

2.

MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells.

De Cola A, Lamolinara A, Lanuti P, Rossi C, Iezzi M, Marchisio M, Todaro M, De Laurenzi V.

Cell Death Dis. 2018 Jul 26;9(8):821. doi: 10.1038/s41419-018-0854-9.

3.

Generation of multiparametric MRI maps by using Gd-labelled- RBCs reveals phenotypes and stages of murine prostate cancer.

Ferrauto G, Di Gregorio E, Lanzardo S, Ciolli L, Iezzi M, Aime S.

Sci Rep. 2018 Jul 12;8(1):10567. doi: 10.1038/s41598-018-28926-5.

4.

In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer.

Gambini V, Tilio M, Maina EW, Andreani C, Bartolacci C, Wang J, Iezzi M, Ferraro S, Ramadori AT, Simon OC, Pucciarelli S, Wu G, Dou QP, Marchini C, Galassi R, Amici A.

Eur J Med Chem. 2018 Jul 15;155:418-427. doi: 10.1016/j.ejmech.2018.06.002. Epub 2018 Jun 2.

PMID:
29906688
5.

Clitoromegaly in Childhood and Adolescence: Behind One Clinical Sign, a Clinical Sea.

Iezzi ML, Lasorella S, Varriale G, Zagaroli L, Ambrosi M, Verrotti A.

Sex Dev. 2018 May 26. doi: 10.1159/000489385. [Epub ahead of print]

6.

Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells.

Castiello L, Sestili P, Schiavoni G, Dattilo R, Monque DM, Ciaffoni F, Iezzi M, Lamolinara A, Sistigu A, Moschella F, Pacca AM, Macchia D, Ferrantini M, Zeuner A, Biffoni M, Proietti E, Belardelli F, Aricò E.

Cancer Immunol Res. 2018 Jun;6(6):658-670. doi: 10.1158/2326-6066.CIR-17-0675. Epub 2018 Apr 5.

PMID:
29622580
7.

Author Correction: The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries.

Grasso S, Chapelle J, Salemme V, Aramu S, Russo I, Vitale N, di Cantogno LV, Dallaglio K, Castellano I, Amici A, Centonze G, Sharma N, Lunardi S, Cabodi S, Cavallo F, Lamolinara A, Stramucci L, Moiso E, Provero P, Albini A, Sapino A, Staaf J, Di Fiore PP, Bertalot G, Pece S, Tosoni D, Confalonieri S, Iezzi M, Di Stefano P, Turco E, Defilippi P.

Nat Commun. 2018 Mar 30;9:16203. doi: 10.1038/ncomms16203.

8.

EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma.

Capone E, Lamolinara A, D'Agostino D, Rossi C, De Laurenzi V, Iezzi M, Iacobelli S, Sala G.

J Control Release. 2018 May 10;277:48-56. doi: 10.1016/j.jconrel.2018.03.016. Epub 2018 Mar 14.

9.

Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment.

Iezzi ME, Policastro L, Werbajh S, Podhajcer O, Canziani GA.

Front Immunol. 2018 Feb 19;9:273. doi: 10.3389/fimmu.2018.00273. eCollection 2018. Review.

10.

EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma.

Capone E, Giansanti F, Ponziani S, Lamolinara A, Iezzi M, Cimini A, Angelucci F, Sorda R, Laurenzi V, Natali PG, Ippoliti R, Iacobelli S, Sala G.

Oncotarget. 2017 Sep 8;8(56):95412-95424. doi: 10.18632/oncotarget.20728. eCollection 2017 Nov 10.

11.

Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy.

Sandri S, De Sanctis F, Lamolinara A, Boschi F, Poffe O, Trovato R, Fiore A, Sartori S, Sbarbati A, Bondanza A, Cesaro S, Krampera M, Scupoli MT, Nishimura MI, Iezzi M, Sartoris S, Bronte V, Ugel S.

Oncotarget. 2017 May 23;8(50):86987-87001. doi: 10.18632/oncotarget.18115. eCollection 2017 Oct 20.

12.

HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response.

Palladini A, Nicoletti G, Lamolinara A, Dall'Ora M, Balboni T, Ianzano ML, Laranga R, Landuzzi L, Giusti V, Ceccarelli C, Santini D, Taffurelli M, Di Oto E, Asioli S, Amici A, Pupa SM, De Giovanni C, Tagliabue E, Iezzi M, Nanni P, Lollini PL.

Oncotarget. 2017 Apr 13;8(33):54444-54458. doi: 10.18632/oncotarget.17088. eCollection 2017 Aug 15.

13.

ATLANTIC-CAMTRAPS: a dataset of medium and large terrestrial mammal communities in the Atlantic Forest of South America.

Lima F, Beca G, Muylaert RL, Jenkins CN, Perilli MLL, Paschoal AMO, Massara RL, Paglia AP, Chiarello AG, Graipel ME, Cherem JJ, Regolin AL, Oliveira Santos LGR, Brocardo CR, Paviolo A, Di Bitetti MS, Scoss LM, Rocha FL, Fusco-Costa R, Rosa CA, Da Silva MX, Hufnagell L, Santos PM, Duarte GT, Guimarães LN, Bailey LL, Rodrigues FHG, Cunha HM, Fantacini FM, Batista GO, Bogoni JA, Tortato MA, Luiz MR, Peroni N, De Castilho PV, Maccarini TB, Filho VP, Angelo C, Cruz P, Quiroga V, Iezzi ME, Varela D, Cavalcanti SMC, Martensen AC, Maggiorini EV, Keesen FF, Nunes AV, Lessa GM, Cordeiro-Estrela P, Beltrão MG, De Albuquerque ACF, Ingberman B, Cassano CR, Junior LC, Ribeiro MC, Galetti M.

Ecology. 2017 Nov;98(11):2979. doi: 10.1002/ecy.1998.

PMID:
28857166
14.

Resveratrol has anti-thyroid effects both in vitro and in vivo.

Giuliani C, Iezzi M, Ciolli L, Hysi A, Bucci I, Di Santo S, Rossi C, Zucchelli M, Napolitano G.

Food Chem Toxicol. 2017 Sep;107(Pt A):237-247. doi: 10.1016/j.fct.2017.06.044. Epub 2017 Jun 28.

PMID:
28668442
15.

Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection.

Codagnone M, Cianci E, Lamolinara A, Mari VC, Nespoli A, Isopi E, Mattoscio D, Arita M, Bragonzi A, Iezzi M, Romano M, Recchiuti A.

Mucosal Immunol. 2018 Jan;11(1):35-49. doi: 10.1038/mi.2017.36. Epub 2017 Apr 19.

PMID:
28422188
16.

The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries.

Grasso S, Chapelle J, Salemme V, Aramu S, Russo I, Vitale N, Verdun di Cantogno L, Dallaglio K, Castellano I, Amici A, Centonze G, Sharma N, Lunardi S, Cabodi S, Cavallo F, Lamolinara A, Stramucci L, Moiso E, Provero P, Albini A, Sapino A, Staaf J, Di Fiore PP, Bertalot G, Pece S, Tosoni D, Confalonieri S, Iezzi M, Di Stefano P, Turco E, Defilippi P.

Nat Commun. 2017 Mar 16;8:14797. doi: 10.1038/ncomms14797. Erratum in: Nat Commun. 2018 Mar 30;9:16203.

17.

Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor.

Andreani C, Bartolacci C, Wijnant K, Crinelli R, Bianchi M, Magnani M, Hysi A, Iezzi M, Amici A, Marchini C.

Aging (Albany NY). 2017 Feb 26;9(2):508-523. doi: 10.18632/aging.101175.

18.

The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis.

Bandini S, Macagno M, Hysi A, Lanzardo S, Conti L, Bello A, Riccardo F, Ruiu R, Merighi IF, Forni G, Iezzi M, Quaglino E, Cavallo F.

Oncoimmunology. 2016 Nov 8;5(12):e1253653. doi: 10.1080/2162402X.2016.1253653. eCollection 2016.

19.

Stories of experiences of care for growth hormone deficiency: the CRESCERE project.

Marini MG, Chesi P, Mazzanti L, Guazzarotti L, Toni TD, Salerno MC, Officioso A, Parpagnoli M, Angeletti C, Faienza MF, Iezzi ML, Aversa T, Sacchetti C.

Future Sci OA. 2016 Feb 25;2(1):FSO82. doi: 10.4155/fso.15.82. eCollection 2016 Mar.

20.

Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer.

Corda G, Sala G, Lattanzio R, Iezzi M, Sallese M, Fragassi G, Lamolinara A, Mirza H, Barcaroli D, Ermler S, Silva E, Yasaei H, Newbold RF, Vagnarelli P, Mottolese M, Natali PG, Perracchio L, Quist J, Grigoriadis A, Marra P, Tutt AN, Piantelli M, Iacobelli S, De Laurenzi V, Sala A.

J Pathol. 2017 Feb;241(3):350-361. doi: 10.1002/path.4841. Epub 2016 Dec 29.

21.

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer.

Castagnoli L, Ghedini GC, Koschorke A, Triulzi T, Dugo M, Gasparini P, Casalini P, Palladini A, Iezzi M, Lamolinara A, Lollini PL, Nanni P, Chiodoni C, Tagliabue E, Pupa SM.

Oncogene. 2017 Mar 23;36(12):1721-1732. doi: 10.1038/onc.2016.338. Epub 2016 Sep 19.

22.

Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.

Carrella D, Manni I, Tumaini B, Dattilo R, Papaccio F, Mutarelli M, Sirci F, Amoreo CA, Mottolese M, Iezzi M, Ciolli L, Aria V, Bosotti R, Isacchi A, Loreni F, Bardelli A, Avvedimento VE, di Bernardo D, Cardone L.

Oncotarget. 2016 Sep 13;7(37):58743-58758. doi: 10.18632/oncotarget.11318.

23.

Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib.

Tilio M, Gambini V, Wang J, Garulli C, Kalogris C, Andreani C, Bartolacci C, Elexpuru Zabaleta M, Pietrella L, Hysi A, Iezzi M, Belletti B, Orlando F, Provinciali M, Galeazzi R, Marchini C, Amici A.

Cancer Lett. 2016 Oct 10;381(1):76-84. doi: 10.1016/j.canlet.2016.07.028. Epub 2016 Jul 27.

PMID:
27475932
24.

Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies.

Sandri S, Bobisse S, Moxley K, Lamolinara A, De Sanctis F, Boschi F, Sbarbati A, Fracasso G, Ferrarini G, Hendriks RW, Cavallini C, Scupoli MT, Sartoris S, Iezzi M, Nishimura MI, Bronte V, Ugel S.

Cancer Res. 2016 May 1;76(9):2540-51. doi: 10.1158/0008-5472.CAN-15-2318.

25.

A unique case of growth hormone and human chorionic gonadotropin treatment in a 45,X male with Y: autosome translocation and literature review.

Mareri A, Iezzi M, Salvatore A, Ligas C, D'Alessandro E.

J Pediatr Endocrinol Metab. 2016 Jul 1;29(7):857-62. doi: 10.1515/jpem-2015-0427. Review.

PMID:
27054600
26.

The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells.

Montani M, Pazmay GVB, Hysi A, Lupidi G, Pettinari R, Gambini V, Tilio M, Marchetti F, Pettinari C, Ferraro S, Iezzi M, Marchini C, Amici A.

Pharmacol Res. 2016 May;107:282-290. doi: 10.1016/j.phrs.2016.03.032. Epub 2016 Mar 30.

PMID:
27038531
27.

Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.

Chikh A, Ferro R, Abbott JJ, Piñeiro R, Buus R, Iezzi M, Ricci F, Bergamaschi D, Ostano P, Chiorino G, Lattanzio R, Broggini M, Piantelli M, Maffucci T, Falasca M.

Oncotarget. 2016 Apr 5;7(14):18325-45. doi: 10.18632/oncotarget.7761.

28.

ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm.

Marchetti A, Di Lorito A, Pace MV, Iezzi M, Felicioni L, D'Antuono T, Filice G, Guetti L, Mucilli F, Buttitta F.

J Thorac Oncol. 2016 Apr;11(4):487-95. doi: 10.1016/j.jtho.2015.12.111. Epub 2016 Feb 22.

29.

Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor.

Lamolinara A, Stramucci L, Hysi A, Iezzi M, Marchini C, Mariotti M, Amici A, Curcio C.

J Immunol Res. 2015;2015:159145. doi: 10.1155/2015/159145. Epub 2015 Jul 13.

30.

Antitumor immunization of mothers delays tumor development in cancer-prone offspring.

Barutello G, Curcio C, Spadaro M, Arigoni M, Trovato R, Bolli E, Zheng Y, Ria F, Quaglino E, Iezzi M, Riccardo F, Holmgren L, Forni G, Cavallo F.

Oncoimmunology. 2015 Feb 3;4(5):e1005500. eCollection 2015 May.

31.

Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis.

Croci S, Nanni P, Palladini A, Nicoletti G, Grosso V, Benegiamo G, Landuzzi L, Lamolinara A, Ianzano ML, Ranieri D, Dall'Ora M, Iezzi M, De Giovanni C, Lollini PL.

Breast Cancer Res. 2015 May 22;17:70. doi: 10.1186/s13058-015-0588-x.

32.

Claudin-4 SPECT Imaging Allows Detection of Aplastic Lesions in a Mouse Model of Breast Cancer.

Mosley M, Knight J, Neesse A, Michl P, Iezzi M, Kersemans V, Cornelissen B.

J Nucl Med. 2015 May;56(5):745-51. doi: 10.2967/jnumed.114.152496. Epub 2015 Apr 3.

33.

Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female Sprague-Dawley rats.

Manservisi F, Gopalakrishnan K, Tibaldi E, Hysi A, Iezzi M, Lambertini L, Teitelbaum S, Chen J, Belpoggi F.

Reprod Toxicol. 2015 Jul;54:110-9. doi: 10.1016/j.reprotox.2014.12.013. Epub 2014 Dec 29.

34.

Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer.

Cornelissen B, Able S, Kartsonaki C, Kersemans V, Allen PD, Cavallo F, Cazier JB, Iezzi M, Knight J, Muschel R, Smart S, Vallis KA.

J Nucl Med. 2014 Dec;55(12):2026-31. doi: 10.2967/jnumed.114.142083. Epub 2014 Nov 13.

35.

Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab.

Castagnoli L, Iezzi M, Ghedini GC, Ciravolo V, Marzano G, Lamolinara A, Zappasodi R, Gasparini P, Campiglio M, Amici A, Chiodoni C, Palladini A, Lollini PL, Triulzi T, Menard S, Nanni P, Tagliabue E, Pupa SM.

Cancer Res. 2014 Nov 1;74(21):6248-59. doi: 10.1158/0008-5472.CAN-14-0983. Epub 2014 Aug 27.

36.

Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series.

Chiari R, Buttitta F, Iacono D, Bennati C, Metro G, Di Lorito A, Iezzi M, Tiseo M, Mazzoni F, Cappuzzo F, Marchetti A, Crinò L.

Clin Lung Cancer. 2014 Nov;15(6):470-4. doi: 10.1016/j.cllc.2014.06.004. Epub 2014 Jun 24. No abstract available.

PMID:
25087901
37.

Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers.

Riccardo F, Arigoni M, Buson G, Zago E, Iezzi M, Longo D, Carrara M, Fiore A, Nuzzo S, Bicciato S, Nanni P, Landuzzi L, Cavallo F, Calogero R, Quaglino E.

BMC Genomics. 2014;15 Suppl 3:S1. doi: 10.1186/1471-2164-15-S3-S1. Epub 2014 May 6.

38.

Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition.

Kalogris C, Garulli C, Pietrella L, Gambini V, Pucciarelli S, Lucci C, Tilio M, Zabaleta ME, Bartolacci C, Andreani C, Giangrossi M, Iezzi M, Belletti B, Marchini C, Amici A.

Biochem Pharmacol. 2014 Aug 1;90(3):226-34. doi: 10.1016/j.bcp.2014.05.014. Epub 2014 May 27.

PMID:
24875448
39.

Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice.

Macagno M, Bandini S, Stramucci L, Quaglino E, Conti L, Balmas E, Smyth MJ, Lollini PL, Musiani P, Forni G, Iezzi M, Cavallo F.

J Immunol. 2014 Jun 1;192(11):5434-41. doi: 10.4049/jimmunol.1301248. Epub 2014 Apr 30.

40.

rBet v 1 immunotherapy of sensitized mice with Streptococcus thermophilus as vehicle and adjuvant.

Petrarca C, Clemente E, Toto V, Iezzi M, Rossi C, Zanotta S, Mistrello G, Zanoni I, Granucci F, Arioli S, Mora D, Guglielmetti S, Paganelli R, Di Gioacchino M.

Hum Vaccin Immunother. 2014;10(5):1228-37. doi: 10.4161/hv.28155. Epub 2014 Mar 6.

41.

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

De Giovanni C, Nicoletti G, Quaglino E, Landuzzi L, Palladini A, Ianzano ML, Dall'Ora M, Grosso V, Ranieri D, Laranga R, Croci S, Amici A, Penichet ML, Iezzi M, Cavallo F, Nanni P, Lollini PL.

Breast Cancer Res. 2014 Jan 23;16(1):R10. doi: 10.1186/bcr3602.

42.

Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice.

Bandini S, Curcio C, Macagno M, Quaglino E, Arigoni M, Lanzardo S, Hysi A, Barutello G, Consolino L, Longo DL, Musiani P, Forni G, Iezzi M, Cavallo F.

Oncoimmunology. 2013 Sep 1;2(9):e26137. Epub 2013 Sep 12.

43.

HER-2/neu mediates oncogenic transformation via altered CREB expression and function.

Steven A, Leisz S, Massa C, Iezzi M, Lattanzio R, Lamolinara A, Bukur J, Müller A, Hiebl B, Holzhausen HJ, Seliger B.

Mol Cancer Res. 2013 Nov;11(11):1462-77. doi: 10.1158/1541-7786.MCR-13-0125. Epub 2013 Sep 11.

44.

Expression of CREB in primary pterygium and correlation with cyclin D1, ki-67, MMP7, p53, p63, Survivin and Vimentin.

Nubile M, Curcio C, Lanzini M, Calienno R, Iezzi M, Mastropasqua A, Di Nicola M, Mastropasqua L.

Ophthalmic Res. 2013;50(2):99-107. doi: 10.1159/000347124. Epub 2013 Jul 3.

PMID:
23838680
45.

Optical imaging detection of microscopic mammary cancer in ErbB-2 transgenic mice through the DA364 probe binding αv β3 integrins.

Conti L, Lanzardo S, Iezzi M, Montone M, Bolli E, Brioschi C, Maiocchi A, Forni G, Cavallo F.

Contrast Media Mol Imaging. 2013 Jul-Aug;8(4):350-60. doi: 10.1002/cmmi.1529.

PMID:
23613438
46.

Pathological changes of the anatomical structure and markers of the limbal stem cell niche due to inflammation.

Nubile M, Curcio C, Dua HS, Calienno R, Lanzini M, Iezzi M, Mastropasqua R, Agnifili L, Mastropasqua L.

Mol Vis. 2013;19:516-25. Epub 2013 Feb 26.

47.

Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.

Nanni P, Gatta V, Menotti L, De Giovanni C, Ianzano M, Palladini A, Grosso V, Dall'ora M, Croci S, Nicoletti G, Landuzzi L, Iezzi M, Campadelli-Fiume G, Lollini PL.

PLoS Pathog. 2013 Jan;9(1):e1003155. doi: 10.1371/journal.ppat.1003155. Epub 2013 Jan 31.

48.

Retrocardiac pneumonia mimicking acute abdomen: a diagnostic challenge.

Pezone I, Iezzi ML, Leone S.

Pediatr Emerg Care. 2012 Nov;28(11):1230-1. doi: 10.1097/PEC.0b013e31827208db.

PMID:
23128653
49.

p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells.

Bisaro B, Montani M, Konstantinidou G, Marchini C, Pietrella L, Iezzi M, Galiè M, Orso F, Camporeale A, Colombo SM, Di Stefano P, Tornillo G, Camacho-Leal MP, Turco E, Taverna D, Cabodi S, Amici A, Defilippi P.

Breast Cancer Res. 2012 Oct 26;14(5):R137. doi: 10.1186/bcr3342.

50.

Human responses against HER-2-positive cancer cells in human immune system-engrafted mice.

De Giovanni C, Nicoletti G, Landuzzi L, Romani F, Croci S, Palladini A, Murgo A, Antognoli A, Ianzano ML, Stivani V, Grosso V, Iezzi M, Stramucci L, Barbieri E, Lemoli RM, Nanni P, Lollini PL.

Br J Cancer. 2012 Oct 9;107(8):1302-9. doi: 10.1038/bjc.2012.394. Epub 2012 Aug 28.

Supplemental Content

Support Center